APA

Hofstra L. S., Bos A. M. E., de Vries E. G. E., van der Zee A. G. J., Willemsen A. T. M., Rosing H., Beijnen J. H., Mulder N. H., Aalders J. G. & Willemse P. H. B. (20020723). Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer. : Gynecologic oncology.

Chicago

Hofstra L S, Bos A M E, de Vries E G E, van der Zee A G J, Willemsen A T M, Rosing H, Beijnen J H, Mulder N H, Aalders J G and Willemse P H B. 20020723. Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer. : Gynecologic oncology.

Harvard

Hofstra L. S., Bos A. M. E., de Vries E. G. E., van der Zee A. G. J., Willemsen A. T. M., Rosing H., Beijnen J. H., Mulder N. H., Aalders J. G. and Willemse P. H. B. (20020723). Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer. : Gynecologic oncology.

MLA

Hofstra L S, Bos A M E, de Vries E G E, van der Zee A G J, Willemsen A T M, Rosing H, Beijnen J H, Mulder N H, Aalders J G and Willemse P H B. Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer. : Gynecologic oncology. 20020723.